McKenzie et al. found a significantly increased GSDMD level in the microglia in the multiple sclerosis humans and animals, while inhibition of GSDMD could dramatically decrease inflammatory factors release, reduce axonal damage and behavioral impairment [7]. The gene discussed is GSDMD; the disease is multiple sclerosis.